Results 321 to 330 of about 168,140 (338)
A commentary on 'Comparison of the efficacy of neoadjuvant chemotherapy and neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients: meta-analysis of randomized controlled trials'. [PDF]
Zhou W, Dan J, Zhu M, Wang Y.
europepmc +1 more source
Case Report: Esophageal cancer under comprehensive treatment strategy-application and clinical outcome analysis of combined immunotherapy, targeted therapy, and low-dose radiotherapy. [PDF]
Yuan Y, Pan X, Tong L, He W, Yang W.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Cancer, 2022
The current standard treatment for patients with inoperable, locally advanced esophageal squamous cell carcinoma (ESCC) is definitive concurrent chemoradiotherapy (CCRT).
Sehhoon Park+6 more
semanticscholar +1 more source
The current standard treatment for patients with inoperable, locally advanced esophageal squamous cell carcinoma (ESCC) is definitive concurrent chemoradiotherapy (CCRT).
Sehhoon Park+6 more
semanticscholar +1 more source
, 2021
8511Background: In the placebo-controlled Phase III PACIFIC trial of patients with unresectable Stage III NSCLC whose disease had not progressed after platinum-based concurrent chemoradiotherapy (c...
D. Spigel+19 more
semanticscholar +1 more source
8511Background: In the placebo-controlled Phase III PACIFIC trial of patients with unresectable Stage III NSCLC whose disease had not progressed after platinum-based concurrent chemoradiotherapy (c...
D. Spigel+19 more
semanticscholar +1 more source
Radiology, 2020
Background Preoperative response evaluation with neoadjuvant chemoradiotherapy remains a challenge in the setting of locally advanced rectal cancer.
Xiaoyan Zhang+8 more
semanticscholar +1 more source
Background Preoperative response evaluation with neoadjuvant chemoradiotherapy remains a challenge in the setting of locally advanced rectal cancer.
Xiaoyan Zhang+8 more
semanticscholar +1 more source